Page last updated: 2024-11-03

ag 1879 and Cardiomegaly

ag 1879 has been researched along with Cardiomegaly in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marin, TM1
Clemente, CF1
Santos, AM1
Picardi, PK1
Pascoal, VD1
Lopes-Cendes, I1
Saad, MJ1
Franchini, KG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis[NCT02737202]Phase 228 participants (Actual)Interventional2016-04-30Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for ag 1879 and Cardiomegaly

ArticleYear
Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
    Circulation research, 2008, Oct-10, Volume: 103, Issue:8

    Topics: Animals; Animals, Newborn; Cardiomegaly; Cell Size; Cells, Cultured; Extracellular Signal-Regulated

2008
chemdatabank.com